Chemokine-like factor 1: A promising therapeutic target in human diseases

Area of Science:

• Immunology
• Molecular Biology
• Oncology

Background:

• Chemokine CKLF1 (CKLF1) is a recently identified chemokine with documented roles in various diseases.
• The precise molecular pathways involving CKLF1 remain incompletely understood.
• CKLF1's involvement in human diseases, particularly tumors, warrants further investigation.

Purpose of the Study:

• To elucidate the molecular structure and primary functions of CKLF1.
• To summarize the known and potential signaling pathways of CKLF1.
• To review the therapeutic implications of CKLF1, including preclinical studies.

Main Methods:

• Literature review of existing studies on CKLF1.
• Analysis of CKLF1 molecular structure and functional data.
• Compilation and visualization of CKLF1 signaling pathways.
• Overview of experimental trials of CKLF1-targeting drugs in animal models.

Main Results:

• Detailed description of CKLF1's basic molecular structure and key functions.
• Comprehensive summary of CKLF1 signaling pathways, presented visually.
• Evidence of CKLF1's implication in various human diseases, with a focus on tumors.
• Preclinical data on CKLF1-targeting medicines in animal models.

Conclusions:

• CKLF1 is a significant chemokine with diverse roles in human health and disease.
• Understanding CKLF1's signaling pathways is crucial for therapeutic development.
• CKLF1-targeting therapies show promise, necessitating further research for clinical application.